Cargando…
Clinical performance of an analytically validated assay in comparison to microarray technology to assess PITX2 DNA-methylation in breast cancer
Significant evidence has accumulated that DNA-methylation of the paired-like homeodomain transcription factor 2 (PITX2) gene can serve as a prognostic and predictive biomarker in breast cancer. PITX2 DNA-methylation data have been obtained so far from microarray and polymerase chain reaction (PCR)-b...
Autores principales: | Schricker, Gabriele, Napieralski, Rudolf, Noske, Aurelia, Piednoir, Elodie, Manner, Olivia, Schüren, Elisabeth, Lauber, Jürgen, Perkins, Jonathan, Magdolen, Viktor, Schmitt, Manfred, Ulm, Kurt, Weichert, Wilko, Kiechle, Marion, Martens, John W. M., Wilhelm, Olaf G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6237923/ https://www.ncbi.nlm.nih.gov/pubmed/30442983 http://dx.doi.org/10.1038/s41598-018-34919-1 |
Ejemplares similares
-
PITX2 DNA-methylation predicts response to anthracycline-based adjuvant chemotherapy in triple-negative breast cancer patients
por: Absmaier, Magdalena, et al.
Publicado: (2018) -
The Predictive Value of PITX2 DNA Methylation for High-Risk Breast Cancer Therapy: Current Guidelines, Medical Needs, and Challenges
por: Aubele, Michaela, et al.
Publicado: (2017) -
First prospective outcome data for the second-generation multigene test Endopredict in ER-positive/HER2-negative breast cancer
por: Ettl, Johannes, et al.
Publicado: (2020) -
Clinical relevance of kallikrein-related peptidase 9, 10, 11, and 15 mRNA expression in advanced high-grade serous ovarian cancer
por: Geng, Xiaocong, et al.
Publicado: (2017) -
Risk stratification in luminal-type breast cancer: Comparison of Ki-67 with EndoPredict test results
por: Noske, Aurelia, et al.
Publicado: (2019)